Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
MILANO VINCENT (CIK 1187159) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-02). Recent activity: Buy BCRX (1,159 shares), Buy BCRX (15,294 shares), Buy ACRS (11,580 shares), Buy BCRX (1,122 shares), Buy BCRX (848 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 1,159 | $11,242 |
| 2026-06-15 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 15,294 | $0 |
| 2026-06-08 | Aclaris Therapeutics, Inc. (ACRS) | Director | Buy | 11,580 | $0 |
| 2026-06-02 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 1,122 | $9,997 |
| 2026-03-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 848 | $7,420 |
| 2025-12-02 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 783 | $5,622 |
| 2025-09-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 676 | $5,618 |
| 2025-06-16 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 12,500 | $0 |
| 2025-06-09 | Aclaris Therapeutics, Inc. (ACRS) | Director | Buy | 4,793 | $0 |
| 2025-06-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 523 | $5,622 |
Source: SEC Form 4 filings · as of 2026-09-02